五部门联合开展医保领域打击欺诈骗保专项整治工作!
发布日期:2023-06-06 10:46:53 浏览次数:34264
作者:社保科
为进一步加强医保基金监管,守住医保基金安全底线,国家医保局、最高人民检察院、公安部、财政部、国家卫生健康委日前印发了《2023年医保领域打击欺诈骗保专项整治工作方案》,在全国范围开展医保领域打击欺诈骗保专项整治工作。
方案明确,将对“假病人”“假病情”等欺诈骗保行为进行重点打击。具体从三个方面着力:一是聚焦骨科、血液净化、心血管内科、检查、检验、康复理疗等重点领域。二是聚焦重点药品、耗材。对2022年医保结算费用排名靠前的重点药品、耗材基金使用情况予以监测,其中药品包括人血白蛋白、阿托伐他汀、硝苯地平、复方丹参片、脑心通丸等,耗材包括血液灌流(吸附)器及套装、磁定位治疗导管、血液透析滤过器等,对其他出现异常增长的药品、耗材等,也予以重点关注。三是聚焦虚假就医、医保药品倒卖等重点行为。对异地就医、门诊统筹政策实施后的易发高发违法违规行为,也专门提出工作要求。
此外,方案进一步明确和细化了医保、检察机关、公安机关、财政及卫生健康五部门在专项整治工作中所承担的职责。
根据方案,2023年国家医保局将在大数据监管方面着重发力,开展大数据监管试点,通过“虚假住院”“医保药品倒卖”“医保电子凭证套现”“重点药品监测分析”等大数据模型筛查可疑线索,并下发各地核查。
标题:五部门联合开展医保领域打击欺诈骗保专项整治工作!。内容:<p style="margin-top: 32px; margin-right: 8px; margin-left: 8px; padding: 0px; outline: 0px; clear: both; min-height: 1em; color: rgba(0, 0, 0, 0.9); font-family: system-ui, -apple-system, BlinkMacSystemFont, "Helvetica Neue", "PingFang SC", "Hiragino Sans GB", "Microsoft YaHei UI", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; letter-spacing: 0.544px; text-align: justify; white-space: normal; background-color: rgb(255, 255, 255); line-height: 1.75em; text-indent: 2em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">为进一步加强医保基金监管,守住医保基金安全底线,国家医保局、最高人民检察院、公安部、财政部、国家卫生健康委日前印发了《</span><span style="padding: 0px; outline: 0px; box-sizing: border-box !important; overflow-wrap: break-word !important;">2023</span><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">年医保领域打击欺诈骗保专项整治工作方案》,在全国范围开展医保领域打击欺诈骗保专项整治工作。</span></p><p><br/></p><p style="margin-top: 24px; margin-right: 8px; margin-left: 8px; padding: 0px; outline: 0px; color: rgba(0, 0, 0, 0.9); font-family: system-ui, -apple-system, BlinkMacSystemFont, "Helvetica Neue", "PingFang SC", "Hiragino Sans GB", "Microsoft YaHei UI", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; letter-spacing: 0.544px; text-align: justify; white-space: normal; background-color: rgb(255, 255, 255); line-height: 1.75em; text-indent: 2em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">方案明确,将对“假病人”“假病情”等欺诈骗保行为进行重点打击。具体从三个方面着力:一是聚焦骨科、血液净化、心血管内科、检查、检验、康复理疗等重点领域。二是聚焦重点药品、耗材。对</span><span style="padding: 0px; outline: 0px; box-sizing: border-box !important; overflow-wrap: break-word !important;">2022</span><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">年医保结算费用排名靠前的重点药品、耗材基金使用情况予以监测,其中药品包括人血白蛋白、阿托伐他汀、硝苯地平、复方丹参片、脑心通丸等,耗材包括血液灌流(吸附)器及套装、磁定位治疗导管、血液透析滤过器等,对其他出现异常增长的药品、耗材等,也予以重点关注。三是聚焦虚假就医、医保药品倒卖等重点行为。对异地就医、门诊统筹政策实施后的易发高发违法违规行为,也专门提出工作要求。</span></p><p style="margin-top: 24px; margin-right: 8px; margin-left: 8px; padding: 0px; outline: 0px; color: rgba(0, 0, 0, 0.9); font-family: system-ui, -apple-system, BlinkMacSystemFont, "Helvetica Neue", "PingFang SC", "Hiragino Sans GB", "Microsoft YaHei UI", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; letter-spacing: 0.544px; text-align: justify; white-space: normal; background-color: rgb(255, 255, 255); line-height: 1.75em; text-indent: 2em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">此外,方案进一步明确和细化了医保、检察机关、公安机关、财政及卫生健康五部门在专项整治工作中所承担的职责。</span></p><p style="margin-top: 24px; margin-right: 8px; margin-left: 8px; padding: 0px; outline: 0px; color: rgba(0, 0, 0, 0.9); font-family: system-ui, -apple-system, BlinkMacSystemFont, "Helvetica Neue", "PingFang SC", "Hiragino Sans GB", "Microsoft YaHei UI", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; letter-spacing: 0.544px; text-align: justify; white-space: normal; background-color: rgb(255, 255, 255); line-height: 1.75em; text-indent: 2em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">根据方案,</span><span style="padding: 0px; outline: 0px; box-sizing: border-box !important; overflow-wrap: break-word !important;">2023</span><span style="padding: 0px; outline: 0px; font-family: 宋体; box-sizing: border-box !important; overflow-wrap: break-word !important;">年国家医保局将在大数据监管方面着重发力,开展大数据监管试点,通过“虚假住院”“医保药品倒卖”“医保电子凭证套现”“重点药品监测分析”等大数据模型筛查可疑线索,并下发各地核查。</span></p><p><br/></p><p><br style="white-space: normal;"/></p><p><br/></p>